Trials / Completed
CompletedNCT04810780
Safety and Efficacy of DUO Extended Set: Combined Glucose Sensor and Infusion Set.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study will follow subjects for 28 days while using an DUO extended infusion set combined with glucose sensor. the objective is to evaluate saftey and efficacy of the set in adult patient with type 1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DUO Extended Set | to evaluate saftey and efficacy of DUO extended set combined with glucose sensor |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-06-01
- Completion
- 2021-12-01
- First posted
- 2021-03-23
- Last updated
- 2022-05-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04810780. Inclusion in this directory is not an endorsement.